Metabolic Dysfunction-Associated Fatty Liver Disease, Statins, and Atherosclerotic Cardiovascular Disease
- PMID: 38061828
- DOI: 10.1016/j.amjmed.2023.07.013
Metabolic Dysfunction-Associated Fatty Liver Disease, Statins, and Atherosclerotic Cardiovascular Disease
Comment in
-
The Reply.Am J Med. 2024 Jan;137(1):e15. doi: 10.1016/j.amjmed.2023.08.024. Am J Med. 2024. PMID: 38061829 No abstract available.
Comment on
-
Cardiovascular Disease Risk and Statin Use Among Adults with Metabolic Dysfunction Associated Fatty Liver Disease.Am J Med. 2023 Jul;136(7):669-676.e1. doi: 10.1016/j.amjmed.2023.03.010. Epub 2023 Mar 30. Am J Med. 2023. PMID: 37001720
Publication types
LinkOut - more resources
Full Text Sources